Abbisko Therapeutics has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly And Co (NYSE: LLY) for novel molecules against an
NetEase, Inc's (NASDAQ: NTES) Cloud Music unit prosecuted Tencent Music Entertainment Group (NYSE: TME) for alleged unfair competition and plagiarizing its app design, Reuters reports.